[Current status of the treatment of hepatic and intestinal amebiasis].
D000563:Amebicides / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004404:Dysentery, Amebic / Q000188:drug therapy*; D006728:Hormones / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008101:Liver Abscess, Amebic / Q000188:drug therapy*; D013607:Tablets
D000563:Amebicides; D000900:Anti-Bacterial Agents; D001152:Arsenicals; D006728:Hormones; D013607:Tablets
Estado actual del tratamiento de la amibiásis intestinal y hepática